STEAP1 is overexpressed in cancers: A promising therapeutic target

Biochemical and Biophysical Research Communications

Volumn 429, Issue 3-4, 2012, Pages 148-155

  Moreaux, Jerome ^a,b   Kassambara, Alboukadel ^b   Hose, Dirk ^d   Klein, Bernard ^a,b,c  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIV MONTPELLIER   (France)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Cancer; Gene expression profiling; STEAP1

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN; PROSTATE PROTEIN; SIX TRANSMEMBRANE EPITHELIAL ANTIGEN OF PROSTATE 1 PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BRAIN TUMOR; COLORECTAL CANCER; EPITHELIUM TUMOR; GENE OVEREXPRESSION; HUMAN; LARGE CELL LYMPHOMA; LYMPHATIC SYSTEM TUMOR; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, NEOPLASM; CELL LINE, TUMOR; HUMANS; IMMUNOTHERAPY; NEOPLASMS; OXIDOREDUCTASES; T-LYMPHOCYTES;

EID: 84870688097     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.123     Document Type: Article

References (40)

1. Hubert R.S., Vivanco I., Chen E., Rastegar S., Leong K., Mitchell S.C., Madraswala R., Zhou Y., Kuo J., Raitano A.B., Jakobovits A., Saffran D.C., Afar D.E. STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc. Natl. Acad. Sci. USA 1999, 96:14523-14528.
2. Rodeberg D.A., Nuss R.A., Elsawa S.F., Celis E. Recognition of six-transmembrane epithelial antigen of the prostate-expressing tumor cells by peptide antigen-induced cytotoxic T lymphocytes. Clin. Cancer Res. 2005, 11:4545-4552.
3. Challita-Eid P.M., Morrison K., Etessami S., An Z., Morrison K.J., Perez-Villar J.J., Raitano A.B., Jia X.C., Gudas J.M., Kanner S.B., Jakobovits A. Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumor xenografts in vivo. Cancer Res. 2007, 67:5798-5805.
4. Machlenkin A., Paz A., Bar Haim E., Goldberger O., Finkel E., Tirosh B., Volovitz I., Vadai E., Lugassy G., Cytron S., Lemonnier F., Tzehoval E., Eisenbach L. Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy. Cancer Res. 2005, 65:6435-6442.
5. Alves P.M., Faure O., Graff-Dubois S., Cornet S., Bolonakis I., Gross D.A., Miconnet I., Chouaib S., Fizazi K., Soria J.C., Lemonnier F.A., Kosmatopoulos K. STEAP, a prostate tumor antigen, is a target of human CD8+ T cells. Cancer Immunol. Immunother. 2006, 55:1515-1523.
6. Krupa M., Canamero M., Gomez C.E., Najera J.L., Gil J., Esteban M. Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progression. Vaccine 2011, 29:1504-1513.
7. Azumi M., Kobayashi H., Aoki N., Sato K., Kimura S., Kakizaki H., Tateno M. Six-transmembrane epithelial antigen of the prostate as an immunotherapeutic target for renal cell and bladder cancer. J. Urol. 2010, 183:2036-2044.
8. Rhodes D.R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., Barrette T., Pandey A., Chinnaiyan A.M. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004, 6:1-6.
9. Tanguy Le Carrour S.A., Tondeur Sylvie, Lhermitte Ludovic, Lamb Ned, Reme Thierry, Pantesco Veronique, Hamamah Samir, Klein Bernard, De Vos John Amazonia!: an online resource to Google and visualize public human whole genome expression data. Open Bioinformat. J. 2010, 4:5-10.
10. Elfilali A., Lair S., Verbeke C., La Rosa P., Radvanyi F., Barillot E. ITTACA: a new database for integrated tumor transcriptome array and clinical data analysis. Nucleic Acids Res. 2006, 34:D613-616.
11. Kassambara A., Klein B., Moreaux J. MMSET is overexpressed in cancers: link with tumor aggressiveness. Biochem. Biophys. Res. Commun. 2009, 379:840-845.
12. Reme T., Hose D., De Vos J., Vassal A., Poulain P.O., Pantesco V., Goldschmidt H., Klein B. A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments. BMC Bioinformatics 2008, 9:16.
13. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., Pastorino S., Purow B.W., Christopher N., Zhang W., Park J.K., Fine H.A. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006, 9:391-403.
14. Hao Y., Triadafilopoulos G., Sahbaie P., Young H.S., Omary M.B., Lowe A.W. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology 2006, 131:925-933.
15. Kimchi E.T., Posner M.C., Park J.O., Darga T.E., Kocherginsky M., Karrison T., Hart J., Smith K.D., Mezhir J.J., Weichselbaum R.R., Khodarev N.N. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res. 2005, 65:3146-3154.
16. Badea L., Herlea V., Dima S.O., Dumitrascu T., Popescu I. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 2008, 55:2016-2027.
17. Segara D., Biankin A.V., Kench J.G., Langusch C.C., Dawson A.C., Skalicky D.A., Gotley D.C., Coleman M.J., Sutherland R.L., Henshall S.M. Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia. Clin. Cancer Res. 2005, 11:3587-3596.
18. Iacobuzio-Donahue C.A., Maitra A., Olsen M., Lowe A.W., van Heek N.T., Rosty C., Walter K., Sato N., Parker A., Ashfaq R., Jaffee E., Ryu B., Jones J., Eshleman J.R., Yeo C.J., Cameron J.L., Kern S.E., Hruban R.H., Brown P.O., Goggins M. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am. J. Pathol. 2003, 162:1151-1162.
19. Singh D., Febbo P.G., Ross K., Jackson D.G., Manola J., Ladd C., Tamayo P., Renshaw A.A., D'Amico A.V., Richie J.P., Lander E.S., Loda M., Kantoff P.W., Golub T.R., Sellers W.R. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 2002, 1:203-209.
20. Welsh J.B., Sapinoso L.M., Su A.I., Kern S.G., Wang-Rodriguez J., Moskaluk C.A., Frierson H.F., Hampton G.M. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 2001, 61:5974-5978.
21. Vanaja D.K., Cheville J.C., Iturria S.J., Young C.Y. Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. Cancer Res. 2003, 63:3877-3882.
22. Ginos M.A., Page G.P., Michalowicz B.S., Patel K.J., Volker S.E., Pambuccian S.E., Ondrey F.G., Adams G.L., Gaffney P.M. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res. 2004, 64:55-63.
23. Toruner G.A., Ulger C., Alkan M., Galante A.T., Rinaggio J., Wilk R., Tian B., Soteropoulos P., Hameed M.R., Schwalb M.N., Dermody J.J. Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet. Cytogenet. 2004, 154:27-35.
24. Ye H., Yu T., Temam S., Ziober B.L., Wang J., Schwartz J.L., Mao L., Wong D.T., Zhou X. Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics 2008, 9:69.
25. Stearman R.S., Dwyer-Nield L., Zerbe L., Blaine S.A., Chan Z., Bunn P.A., Johnson G.L., Hirsch F.R., Merrick D.T., Franklin W.A., Baron A.E., Keith R.L., Nemenoff R.A., Malkinson A.M., Geraci M.W. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am. J. Pathol. 2005, 167:1763-1775.
26. Su L.J., Chang C.W., Wu Y.C., Chen K.C., Lin C.J., Liang S.C., Lin C.H., Whang-Peng J., Hsu S.L., Chen C.H., Huang C.Y. Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC Genomics 2007, 8:140.
27. Wachi S., Yoneda K., Wu R. Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics 2005, 21:4205-4208.
28. Garber M.E., Troyanskaya O.G., Schluens K., Petersen S., Thaesler Z., Pacyna-Gengelbach M., van de Rijn M., Rosen G.D., Perou C.M., Whyte R.I., Altman R.B., Brown P.O., Botstein D., Petersen I. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA 2001, 98:13784-13789.
29. Hou J., Aerts J., den Hamer B., van Ijcken W., den Bakker M., Riegman P., van der Leest C., van der Spek P., Foekens J.A., Hoogsteden H.C., Grosveld F., Philipsen S. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One 2010, 5:e10312.
30. Landi M.T., Dracheva T., Rotunno M., Figueroa J.D., Liu H., Dasgupta A., Mann F.E., Fukuoka J., Hames M., Bergen A.W., Murphy S.E., Yang P., Pesatori A.C., Consonni D., Bertazzi P.A., Wacholder S., Shih J.H., Caporaso N.E., Jen J. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One 2008, 3:e1651.
31. Basso K., Margolin A.A., Stolovitzky G., Klein U., Dalla-Favera R., Califano A. Reverse engineering of regulatory networks in human B cells. Nat. Genet. 2005, 37:382-390.
32. Andersson A., Ritz C., Lindgren D., Eden P., Lassen C., Heldrup J., Olofsson T., Rade J., Fontes M., Porwit-Macdonald A., Behrendtz M., Hoglund M., Johansson B., Fioretos T. Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status. Leukemia 2007, 21:1198-1203.
33. Durig J., Bug S., Klein-Hitpass L., Boes T., Jons T., Martin-Subero J.I., Harder L., Baudis M., Duhrsen U., Siebert R. Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32). Leukemia 2007, 21:2153-2163.
34. Grunewald T.G., Diebold I., Esposito I., Plehm S., Hauer K., Thiel U., da Silva-Buttkus P., Neff F., Unland R., Muller-Tidow C., Zobywalski C., Lohrig K., Lewandrowski U., Sickmann A., da Costa O.P., Gorlach A., Cossarizza A., Butt E., Richter G.H., Burdach S. STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors. Mol. Cancer Res. 2012, 10:52-65.
35. Kassambara A., Hose D., Moreaux J., Walker B.A., Protopopov A., Reme T., Pellestor F., Pantesco V., Jauch A., Morgan G., Goldschmidt H., Klein B. Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma. Haematologica 2011.
36. Zhan F., Huang Y., Colla S., Stewart J.P., Hanamura I., Gupta S., Epstein J., Yaccoby S., Sawyer J., Burington B., Anaissie E., Hollmig K., Pineda-Roman M., Tricot G., van Rhee F., Walker R., Zangari M., Crowley J., Barlogie B., Shaughnessy J.D. The molecular classification of multiple myeloma. Blood 2006, 108:2020-2028.
37. Boswell C.A., Mundo E.E., Zhang C., Bumbaca D., Valle N.R., Kozak K.R., Fourie A., Chuh J., Koppada N., Saad O., Gill H., Shen B.Q., Rubinfeld B., Tibbitts J., Kaur S., Theil F.P., Fielder P.J., Khawli L.A., Lin K. Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats. Bioconjugate Chem. 2011, 22:1994-2004.
38. Pan Y.Z., Li Y., Guo L.R., Zhao Y.Y., Zhao X.J. Influence of expression of six transmembrane epithelial antigen of the prostate-1 on intracellular reactive oxygen species level and cell growth: an in vitro experiment. Zhonghua Yi Xue Za Zhi 2008, 88:641-644.
39. Luo J., Solimini N.L., Elledge S.J. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009, 136:823-837.
40. Szatrowski T.P., Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991, 51:794-798.